Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe in South African patients with hypercholesterolemia
NCT00457275Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Apr 2005
- Primary completion
- Nov 2005
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of ezetimibe in hypercholesterolemia, sponsored by Organon & Co. Primary endpoint: Low-Density Lipoprotein Cholesterol reduction at 4 weeks. Started Apr 2005; status: completed.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00457275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00457275.